Table 2. The clinico-pathological characteristics of enrolled participants.
| Characteristic | Placebo group (n = 30) |
Probiotics group (n = 30) |
P value |
|---|---|---|---|
| Gender | 0.604 | ||
| Female | 18 | 15 | |
| Male | 12 | 15 | |
| Mean Age (years) | 62.17 ± 11.06 | 63.90 ± 12.25 | 0.567 |
| Body mass index (kg/m2) | 22.07 ± 1.70 | 22.13 ± 1.77 | 0.895 |
| Tumor location (n) | |||
| Left hemicolon | 14 | 13 | 0.855 |
| Right hemicolon | 7 | 6 | |
| Rectum | 9 | 11 | |
| TNM stage (n) | |||
| 0 - II | 21 | 23 | 0.771 |
| III | 9 | 7 | |
| Tumor differentiation (n) | |||
| Well-moderate | 27 | 25 | 0.707 |
| Poor | 3 | 5 | |
| Preoperative blood index | |||
| Leucocyte (*109/L) | 6.56 ± 2.54 | 6.14 ± 1.47 | 0.437 |
| Hemoglobin (g/L) | 116.20 ± 21.46 | 121.3 ± 22.08 | 0.371 |
| Albumin (g/L) | 38.5 ± 6.51 | 40.43 ± 5.41 | 0.216 |
| Creatinine (umol/L) | 67.1 ± 18.74 | 72.24 ± 22.85 | 0.345 |
| Glucose (mmol/L) | 5.43 ± 1.03 | 5.39 ± 0.67 | 0.858 |
| Triglyceride (mmol/L) | 1.56 ± 0.91 | 1.27 ± 0.50 | 0.353 |
| Total cholesterol (mmol/L) | 4.36 ± 0.98 | 3.95 ± 1.36 | 0.530 |
| Length of operation (min) | 128.34 ± 36.58 | 128.12 ± 28.31 | 0.979 |
| Perioperative bleeding (mL) | 116.60 ± 29.79 | 123.40 ± 30.50 | 0.388 |
| Intraoperative gut cleanliness (n) | |||
| Excellent | 12 | 19 | 0.073 |
| Good or fair | 16 | 10 | |
| Fair | 2 | 1 |